Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients
Background: Childhood refractory mycoplasma pneumoniae (MP) pneumonia (RMPP) is a lung disease with elevated level of C-reactive protein and severe clinical and radiological deterioration. Whether bacterial co-infection contributes to disease of RMPP and whether inclusion of non-anti-MP antibiotics...
Main Authors: | Jin-Rong Liu, Jie Lu, Fang Dong, Hui-Min Li, Hui Liu, Xiao-Lei Tang, Yong-Li Guo, Shun-Ying Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2018.00296/full |
Similar Items
-
Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia
by: Xia Huang, et al.
Published: (2021-01-01) -
Low-Dose Corticosteroid Treatment in Children With Mycoplasma pneumoniae Pneumonia: A Retrospective Cohort Study
by: Liya Zhang, et al.
Published: (2020-11-01) -
Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children
by: Yi-Chen Lee, et al.
Published: (2021-08-01) -
The correlation between vitamin a status and refractory Mycoplasma Pneumoniae pneumonia (RMPP) incidence in children
by: Yuanyuan Li, et al.
Published: (2020-07-01) -
Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children
by: Meijuan Wang, et al.
Published: (2014-12-01)